NCT05866380Active, not recruiting
Early Identification of Heart Failure in a High-Risk Diabetic Cohort
Early Identification of Heart Failure in Diabetes With Known Cardiovascular Risk or Established Cardiovascular Disease in A Large-scale Asian Diabetic Population: A Multi-center Cohort Study
Source: ClinicalTrials.gov · Last updated 15 Apr 2025
Brief summary (registry, in English)
Type 2 diabetes is an important co-morbid condition strongly associated with the risk of developing heart failure (HF). Risk scores such as the WATCH-DM score that predict the occurrence of HF among diabetes patients are largely based on data collected from white ethnicities. Here, the investigators sought to investigate surrogate markers for predicting HF among type 2 diabetes patients of Asian ethnicities.
- Status (registry)
- Active, not recruiting
- Study type
- Observational
- Enrollment
- 3500 (estimated)
- First submitted
- 8 May 2023
- Start date
- 23 Mar 2022
- Primary completion date
- 1 Mar 2025
- Lead sponsor
- Mackay Memorial Hospital
- Diseases
- Heart failure
- NCT number
- NCT05866380
What you commit to
- Study type: Observational
- Planned participants: 3500
- From 23 Mar 2022 to the primary completion date, 1 Mar 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Any terminal disease other than diabetes lowering the patient's life expectancy to less than two years;
Lab values
- eGFR \<30ml/min/1.73m2;
- Known impaired LV systolic function (LVEF\<40%) by any imaging modality;
Other
- Known HF hospitalization history;
- Pregnant women.
Who the study is looking for
- Type 2 diabetes T2DM for at least six months;
- ≥ 20 years of age, men or women;
- Patients who had either established cardiovascular disease or additional cardiovascular risk factors;
- Free at baseline of diagnosed HF, while patients might be stage A-B HF based on ACC/AHA Heart Failure Classification, with baseline clinical information and NTproBNP data available;
- Baseline patient-level clinical data available.
Age in the registry: 20 years to 100 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| MacKay Memorial Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.